Personnel
Daniel S. Lynch appointed to US Oncology board
Published in Cancer Weekly, September 12th, 2006
Lynch also has been appointed to the audit committee of the board of directors of each company.
From 2001 until 2005, Lynch was employed by Imclone Systems Incorporated, a publicly traded biotechnology company, serving as its chief financial officer from 2001 until 2003 and as its chief executive officer and a member of its board of directors from 2003 until 2005. Prior to that time, he served as chief financial officer of Derby Cycle Corporation, a designer, manufacturer and marketer of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-12)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer outcome associated with status of p53 and MDM2 SNP309 - Crohn Colitis
Crohn colitis patients requiring surgery linked to higher risk of dysplasia and adenocarcinoma - End-of-Life Issues
End-of-life cancer patients' spiritual needs measured by Spiritual Needs Inventory - Endometrial Cancer
Endometrioid endometrial carcinoma's loss of PTEN expression linked to cyclin D1 overexpression - Lung Cancer
Lung cancer patients could safely receive higher doses of radiation than traditionally administered - Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia remission is likely when lymphangiogenesis factor is absent - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
